

In a significant strategic shift discussed during its third-quarter 2026 earnings call, Spectral AI (MDAI -20.61%) is evolving from a research-centric institution into a commercial powerhouse in medical technology. The transition entails a focus on commercial software revenue, diverging from its dependency on government funding. Three strategic highlights from the management team delineate this move. 1. Launch of DeepView AI System Manufacturing Spectral AI has initiated the manufacturing of its first set of 30 DeepView AI units—a cutting-edge AI-driven wound assessment technology—aimed at supporting hospital units under government auspices. These units are designated for deployment at U.S. burn centers through BARDA support, laying the groundwork for a wider commercial campaign set to kick-off in 2026. During this quarter, we began manufacturing the initial 30 DeepView AI systems for BARDA-supported deployments at U.S. burn centers.-- Vincent Stanley Capone, CEO 2. Application for Medicare NTAP Reimbursement In pursuit of facilitating technology adoption in hospitals, Spectral AI has filed for a New Technology Add-on Payment (NTAP) with the Centers for Medicare and Medicaid Services (CMS). If approved, this could yield an additional Medicare reimbursement of $2,750 per patient, channeling financial support to healthcare facilities. Early in the third quarter, we submitted a new technology add-on payment or NTAP application to the Centers for Medicare and Medicaid Services for our DeepView system.-- Vincent Stanley Capone, CEO 3. Profitable Long-Term Software Leases Emphasizing commercial agreements with a minimum three-year commitment, Spectral AI strategically interweaves device access with ongoing software subscriptions. This approach is anticipated to yield higher margins as the installed user base augments over time. Our commercial model pairs device purchases or leases with recurring software and service revenue under agreements with a minimum 3-year term...-- David McGuire, CFO Future Prospects By focusing on routine burn care alongside readiness for mass casualty scenarios, Spectral AI plans to broaden its commercial landscape. Success in clinical validation and hospital procurement will be pivotal to this strategy. While preparedness remains an important component of our strategy, we believe the much greater opportunity is to make this technology available as part of the clinical protocol for everyday burn care.-- Vincent Stanley Capone, CEO Looking forward, sustainable growth hinges on extending hospital presence, obtaining favorable reimbursements, and fortifying subscription-based revenue streams. Our focus is on delivering for our initial customers, learning from each deployment, and establishing the process that can support a broader adoption across the United States.-- Vincent Stanley Capone, CEO